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Physiological concentrations of glucose that lead to Ca#+ entry
and insulin secretion activate extracellular signal-regulated pro-
tein kinases (ERK1 and ERK2) in the MIN6 pancreatic b-cell
line. Here we show that this activation is inhibited by the down-
regulation of protein kinase C (PKC) and by genistein, an
inhibitor of protein tyrosine kinases. In contrast with results
obtained in other cell types, neither the epidermal growth factor
activity nor the Src family protein tyrosine kinases seem to be
involved in the Ca#+-dependent activation of ERKs. inhibition of
tyrosine phosphatases by vanadate leads to the activation of
ERKs. As observed in the response to glucose, this activation is
dependent on Ca#+ entry through L-type voltage-dependent Ca#+
channels. Thus the activation of ERKs in response to glucose
INTRODUCTION
Mitogen-activated protein (MAP) kinases are serine}threonine
kinases involved in many regulatory processes of eukaryotic
cells. The best studied MAP kinases are the extracellular signal-
regulated protein kinases ERK1 and ERK2, which are implicated
in mitosis, cell differentiation and specialized responses to
changes in the extracellular medium [1,2]. The activation of
ERK1 and ERK2 results from phosphorylation by the MAP}
ERK kinases, MEK1 and MEK2, which are themselves regulated
by several Raf kinase isoforms. The mechanisms of Raf activation
are complex and vary with the stimulus and the cellular system
[3]. In the best known systems they involve a small GTP-binding
protein such as Ras and a protein tyrosine kinase, pp60c-src.
Activation of the MAP kinase pathway occurs in response to the
initial activation of receptor or non-receptor tyrosine kinases, the
inhibition of protein tyrosine phosphatases or the activation of
protein kinase C (PKC) [4]. ERKs respond to growth factors and
cytokines and also to an elevation of the cytoplasmic con-
centration of Ca#+ [5].
Changes in the cytoplasmic concentration of Ca#+ also have a
pivotal role in the regulation of exocytosis. Pancreatic b-cells
secrete insulin in response to an elevation of the concentration
of glucose in the blood. After the catabolism of glucose, the
ATP-to-ADP ratio increases, leading to the closure of the ATP-
dependent K+ (K
ATP
) channels and the depolarization of the
plasma membrane. The secretion of insulin is in turn activated by
an entry of Ca#+ into the cells through the L-type voltage-gated
Ca#+ channels. We have recently shown that this Ca#+ entry leads
Abbreviations used: CAT, chloramphenicol acetyltransferase ; DMEM, Dulbecco’s modified Eagle’s medium; EGF, epidermal growth factor ; ERK,
extracellular signal-regulated protein kinase ; IUF1, insulin upstream factor ; K50, 50 mM extracellular K+ ; MAP kinase, mitogen-activated protein kinase ;
MEK, MAP kinase/ERK kinase ; PKC, protein kinase C; TBST, Tris-buffered saline containing Tween 20.
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depends on PKC and possibly on a tyrosine kinase}tyrosine
phosphatase couple. To define the role of ERK activation by
glucose we studied the regulation of transcription of the insulin
gene. We found that this transcription is regulated in the MIN6
cells in the same range of glucose concentration as in primary
islets, and that specific inhibition of mitogen-activated protein
kinase kinase, the direct activator of ERK, impaired the response
of the insulin gene to glucose. This was observed by analysis of
the transfected rat insulin I gene promoter activity and a Northern
blot of endogenous insulin mRNA.
Key words: Ca#+, epidermal growth factor receptor, protein
kinase C, Src family kinases.
to the activation of the MAP kinases ERK1 and ERK2 in the
pancreatic b-cell line MIN6 [6] ; these cells secrete insulin in
response to physiological concentrations of glucose [7].
Insulin biosynthesis is regulated at the levels of both translation
and transcription, but short-term regulation seems to occur
mainly at the translational level [8]. We have previously shown
that the inhibition of the activation of ERKs does not impair the
secretion of insulin in short-term (1 h) experiments and that
ERKs are rapidly translocated into the nucleus after stimulation
by glucose [6], suggesting their implication in transcriptional
regulation. A potential target for this regulation is the insulin
gene itself.
The aim of this study was to characterize further the mech-
anisms of the activation of ERKs in response to glucose, and to
determine whether ERKs have a role in the regulation of insulin
gene transcription.
EXPERIMENTAL
Number of experiments
All the results presented here were obtained from at least three
independent experiments.
Cell culture and stimulation
The MIN6 cells were cultured as described previously [7], in
Dulbecco’s modified Eagle’s medium (DMEM) containing
25 mM glucose and supplemented with 15% (v}v) heat-
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inactivated fetal calf serum. Before treatment with reagents, the
cells were washed twice in the incubation buffer (IB), which
contained 124 mM NaCl, 5.6 mM KCl, 2.5 mM CaCl
#
, 2.5 mM
MgCl
#
, 20 mM Hepes, pH 7.0, and 2.8 mM glucose. Before
stimulation the cells were incubated for 1 h in IB at 37 °C.
Stimulation with the various reagents was performed at 37 °C
and stopped at different times by removal of the buffer and
immediate cell lysis on ice. In Ca#+-free experiments, after
preincubation, the cells were incubated for 15 min in Ca#+-free IB
containing 1 mM EGTA and stimulated in the same buffer. The
stimulation with elevated extracellular K+ concentration was
done by increasing the K+ concentration to 50 mM and de-
creasing the Na+ concentration to 79.6 mM to maintain iso-
tonicity (K50) : 79.6 mM NaCl}50 mM KCl}2.5 mM CaCl
#
}
2.5 mM MgCl
#
}20 mM Hepes (pH 7.0)}2.8 mM glucose.
Preparation of protein extracts
Cells were lysed in cold lysis buffer containing 1% (v}v) Nonidet
P40, 0.1% SDS, 158 mM NaCl, 10 mM Tris, pH 7.8, 1 mM
PMSF and 1 mM Na
$
VO
%
. Protein extracts were prepared at
4 °C. After lysis, the lysates were collected and centrifuged for
15 min at 12000 g. The pellets were discarded. With c-globulin
as a standard the protein concentration in the supernatants was
determined by the Bradford microassay method (Bio-Rad). The
protein extracts were used immediately for immunoblotting
analysis.
Immunoblotting
Equal amounts of protein (40–50 lg) were separated by SDS}
PAGE [10% (w}v) gel] and transferred electrophoretically to a
nitrocellulose membrane (Schleicher and Schuell). The nitro-
cellulose membrane was incubated for 1 h with 1% (w}v) gelatin
in Tris-buffered saline [10 mM Tris}HCl (pH 7.5)}150 mM
NaCl] containing 0.05% (v}v) Tween 20 (TBST) to block non-
specific binding. The anti-(active ERK) antibody (dilution
1:20000; Promega) used recognizes the doubly phosphorylated
MAP kinases ERK1 and ERK2 on the activating sites cor-
responding to residues 183 and 185 in ERK2. The membrane was
washed extensively with TBST and incubated for 1 h with
horseradish peroxidase-conjugated goat anti-(rabbit IgG) (di-
lution 1:10000; Dako), then washed with TBST. The bands were
detected by enhanced chemiluminescence (ECL2 ; Amersham).
Before reprobing with the polyclonal anti-ERK2 C-14 antibody
(dilution 1:1000; sc154; Santa Cruz) (this antibody recognizes
ERK2 and also, weakly, ERK1), the anti-(active ERK) antibody
was washed away by incubation for 2 h at 60 °C in 100 mM 2-
mercaptoethanol}2% (w}v) SDS}62.5 mM Tris}HCl (pH 6.8),
followed by extensive washing in water and incubation (15 min,
twice) in TBST. Polyclonal anti-PKC antibody against the e
isoform (Gibco BRL) was used at 1:2000 dilution. Monoclonal
antibodies against the a, bI and c isoforms (Seikagaku) were
used at 1:200 dilution. Polyclonal anti-(PKC bII) antibody
(Santa Cruz Biotechnology) was used at 1:1000 dilution.
Measurement of cytosolic concentration of Ca2+
MIN6 cells were grown on glass coverslips for 3 days before the
experiments. The cells were loaded with 5 lM fura-2 acetoxy-
methyl ester during a 60 min incubation at 37 °C in a Hepes-
buffered medium, pH 7.4, containing 124 mM NaCl, 5.9 mM
KCl, 2.5 mM CaCl
#
, 1.2 mM MgCl
#
, 1.8 mM glucose and 0.1%
BSA. After being loaded, the cells were washed with the same
buffer and placed at the bottom of an open perifusion chamber
built for microscopic work. The chamber was placed on the stage
of an inverted fluorescence microscope (Diaphot ; Nikon) and
maintained at 37 °C in a climate box. A flow rate of 1 ml}min
was used during the whole experiment. The time necessary for a
complete change of the medium in the chamber was 140 s. This
delay was taken into account in the graphical representations.
The microscope was equipped with a ‹40 fluor oil-immersion
objective. A selected area of the cells was excited at 340 and
380 nm alternately (every 2 s) and the fluorescence intensity
emitted at 510 nm was measured by using a PhotoscanII micro-
fluorimeter (Photon Technology International, Kontron,
France). Photodamage of the islet cells was minimized by using
the smallest amount of illumination required. Background fluor-
escence was recorded for both wavelengths in areas void of cells
and the results were subtracted from the corresponding measure-
ments of fura-2-loaded islets. The measurements of successive
340 nm}380 nm fluorescence ratios reflect the cytosolic concen-
tration of Ca#+ [9,10].
Plasmids
The previously described rINS-I-Cat plasmid [11], corresponding
to a portion of the rat insulin I gene promoter and extending
from the transcription start point to fi410 bp, was a gift from H.
Edlund (University of Umea/ , Umea/ , Sweden). RSV-LacZ ex-
pressing the b-galactosidase gene from Escherichia coli under the
control of the Rous sarcoma virus early promoter was a gift from
I. Sansal (Institut Gustave Roussy, Paris, France). DNA was
prepared by using the Qiagen maxiprep method and quantified
spectrophotometrically.
Transfections
MIN6 cells at 50% confluence were transfected with 4 lg of
DNA with the use of a cationic lipid method (Clonfectin ;
Clontech). For each condition in one experiment, three plates
were transfected simultaneously and the lysates were pooled to
assay the expression of chloramphenicol acetyltransferase (CAT)
and b-galactosidase. Cells were incubated for 7 h with the
lipid–DNA complex in DMEM containing 25 mM glucose, then
washed with PBS and incubated for 36 h in DMEM containing
0.7% BSA and different concentrations of glucose in the presence
or absence of 95 lM PD98059, as indicated in the Figure legends.
CAT and b-galactosidase assays
The expression of CAT was measured with a Boehringer Mann-
heim ELISA kit in accordance with the manufacturer’s protocol.
The cells were lysed in the lysis buffer provided and the extract
was used for CAT and b-galactosidase assays. After the de-
termination of protein concentration, the same amount of protein
(150 lg) was used for each condition and the measurements were
done in duplicate. The RSV-LacZ plasmid was used as a control
for transfection efficiency. The b-galactosidase assay was done
by the method of Hall et al. [12]. The results presented were
obtained from five independent experiments and normalized for
b-galactosidase expression.
Northern blot analysis of insulin mRNA
Cells were rinsed with PBS and scraped in denaturing solution
[4 M guanidine thiocyanate}25 mM sodium citrate (pH 7)}0.5%
sarcosyl}0.1 M 2-mercaptoethanol]. RNA was isolated by the
method of Chomczynski and Sacchi [13]. Total RNA (10 lg) was
separated on a 1.5% (w}v) agarose}formaldehyde gel and
transferred to a nylon hybridization membrane (Hybond N+ ;
Amersham Pharmacia Biotech) by electroblotting. The mem-
brane was prehybridized overnight in 50% (v}v) formamide}
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5‹SSC}5‹Denhardt’s}50 mM sodium phosphate}0.1 mg}ml
salmon sperm DNA}0.1% SDS at 42 °C, then hybridized for
16 h with a $#P-labelled Syrian hamster preproinsulin cDNA
probe [14] in the same solution. The membrane was washed three
times at room temperature in 2‹SSC}0.1% SDS, then twice at
60 °C in 0.2‹SSC}0.1% SDS and exposed to X-ray films
(Kodak Biomax) for 1 h. Under the hybridization conditions
used, the probe hybridized with a single 0.5 kb band from the
agarose-gel fractionation of total MIN6 cell RNA. Membranes
were stripped for 2 h at 75 °C in 1 mM Tris}HCl (pH 8.0)}1 mM
EDTA}0.1‹Denhardt’s, then rehybridized with a $#P-labelled
oligonucleotide probe specific for 18 S ribosomal RNA to control
for variations in the amount of total RNA.
RESULTS AND DISCUSSION
Implication of PKC in the activation of ERKs by glucose
In a previous study we had observed that ERK2 (p42 MAP
kinase) and ERK1 (p44 MAP kinase) are regulated by Ca#+ entry
through L-type voltage-gated Ca#+ channels in MIN6 cells [6]. In
particular, a physiological concentration of glucose results in the
rapid activation and nuclear translocation of ERKs [6]. Inhibition
of the activation of ERKs by the PKC inhibitors GF109203-X
and RO 31-8220 [6] suggested a role for PKCs. To analyse this
point further, we determined whether the activation of ERKs by
glucose was still possible after the down-regulation of PKCs by
prolonged treatment with PMA. MIN6 cells were incubated for
18 h with 1 lM PMA; as expected, this resulted in a marked
inhibition of the activation of ERKs in response to glucose
(Figure 1A). In contrast, the rapid and transient Ca#+-dependent
activation of ERKs that we had observed previously after
treatment of the MIN6 cells with a depolarizing concentration of
extracellular K+ [6] was almost unaltered by treatment with
PMA. Therefore one or more PKC isoforms are involved in the
activation of ERKs by glucose but not by 50 mM K+ (K50).
To determine which of the Ca#+-sensitive PKC isoforms
expressed in MIN6 cells was down-regulated by PMA, immuno-
blots were performed before and after 18 h of PMA treatment.
The two Ca#+-sensitive isoforms PKC bII (80 kDa) and PKC a
(80 kDa) were fully down-regulated by PMA; the other Ca#+-
sensitive PKC isoforms described, b1 and c, were not detected in
MIN6 cells (Figure 1B) (a hippocampal extract was used as a
control for PKC expression [15]). The Ca#+-insensitive, PMA-
sensitive isoform PKCe (92 kDa) was not down-regulated, il-
lustrating that down-regulation does not occur for all PMA-
sensitive isoforms of PKC (Figure 1B). In fact, it has previously
been shown that PKCe is less sensitive to down-regulation by
PMA than the a and b isoforms [16–18].
Previous studies have shown that the a isoform is translocated
to the plasma membrane in response to glucose [19] and we
observed in immunofluorescence experiments that the bII isoform
was already located at the plasma membrane under non-
stimulating conditions (results not shown).
The activation of ERKs by K50 is not affected by the down-
regulation of PKC; stimulation of the cells by glucose still leads
to a partial activation of ERKs. However, the activation of
ERKs in response to glucose or K50 is completely blocked in the
presence of the L-type voltage-gated Ca#+ channel blocker
nifedipine [6]. Given that the two Ca#+-sensitive isoforms of PKC
are almost completely down-regulated by PMA it is likely that a
Ca#+-dependent pathway that does not use these PKCs leads to
the activation of the ERKs in our system. Alternatively, because
the K
ATP
channels are involved in the response to glucose but not
to K50, PKC down-regulation could have decreased their sen-
sitivity to glucose.
Figure 1 Activation of ERKs by glucose depends on PKC
(A) MIN6 cells were pretreated for 18 h with or without 1 lM PMA in DMEM containing 15%
(v/v) heat-inactivated fetal calf serum. Before the stimulation the cells were preincubated for 1 h
at 37 °C with 2.8 mM glucose. Stimulation was performed at 37 °C by adding either glucose
(16.7 mM) or PMA (1 lM) for the indicated durations or with an isotonic buffer containing
50 mM K+ and 2.8 mM glucose (K50). Immunoblots were performed with anti-(active ERK)
antibody (top two rows of panels) and anti-ERK2 antibody (bottom panels). The two bands
revealed by the anti-ERK antibody corresponded to ERK1 and ERK2. Two different exposures
of the film are shown for anti-(active ERK) immunoblotting. (B) Upper panels : lysates of
unstimulated cells either pretreated or not with 1 lM PMA for 18 h were analysed for the
expression of several isoforms of PKC. Lower panels : the expression of the other two Ca2+-
sensitive PKC isoforms was analysed by immunoblotting with a lysate of rat hippocampus as
a control. Hp, hippocampal extract ; M6, MIN6 cell extract.
In contrast with the results presented here, we had previously
shown that two inhibitors of PKC (GF109203X and RO31-8220)
inhibit the activation of ERKs in response to glucose or K50 [6].
We speculate that these inhibitors act on a PKC isoform that is
not down-regulated by PMA and that this isoform allows the
activation of the ERKs in response to glucose and K50. This
PKC might act through the regulation of the voltage-activated
Ca#+ channels.
Taken together, these results show that PKCs are involved in
the regulation of the response of the MAP kinases to glucose but
they do not demonstrate that a PKC is involved in the pathway
linking Ca#+ entry to the activation of the ERKs.
Protein tyrosine kinases are involved in the regulation of ERKs
by Ca2+
In several cell types the activation of ERKs after an elevation of
cytoplasmic Ca#+ concentration was found to involve protein
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Figure 2 Inhibition of the Ca2+-dependent activation of ERKs by genistein
but not by AG1478
(A) Cells were stimulated for 5 min in the presence of the indicated concentrations of glucose
(in mM) or depolarized by incubation with 50 mM extracellular K+ (K50). Genistein was added
during the preincubation step. For each stimulus, genistein was used at 0, 10, 25, 50 and
100 lM. (B) Cells were stimulated for 5 min with 5 or 40 ng/ml EGF or with 10 mM glucose.
AG1478 at a final concentration of either 100 (›) or 250 nM (››) was added 15 min before
the stimulation. Immunoblots were performed with anti-(active ERK) antibody (upper panels) and
anti-ERK2 antibody (lower panels).
tyrosine kinases [5]. To analyse this point in MIN6 cells we used
the protein tyrosine kinase inhibitor genistein. Incubation of the
cells for 1 h with genistein inhibited the activation of ERKs by
glucose or K50 in a concentration-dependent manner (Figure
2A), indicating that this activation is likely to depend on a
protein tyrosine kinase activity.
In PC12 cells, the regulation of ERKs by Ca#+ entry was
shown to occur through transactivation of the epidermal growth
factor (EGF) receptor [20,21]. We therefore investigated whether
inhibition of the activation of ERKs by genistein in MIN6 cells
could reflect an inhibition of the EGF receptor. Incubation of
MIN6 cells with the selective EGF receptor inhibitor AG1478 at
100 nM abolished the activation of ERKs after treatment with
EGF but had only a weak effect on their activation by 10 mM
glucose, even at 250 nM (Figure 2B). Therefore EGF receptor
kinase activity is unlikely to be involved in the activation of
ERKs in response to glucose. However, the possibility remains
that the EGF receptor is involved in our system without any
requirement for its intrinsic kinase activity. Indeed, phosphoryl-
ation of the EGF receptor after the activation of G-protein-
linked receptors has been shown to lead to the activation of ERK
either with or without requirement for its intrinsic activity
[22,23].
The protein tyrosine kinases of the Src family, for instance
p60c-src and p59-fyn, have also been shown to have a role in the
activation of ERKs in response to Ca#+ [24,25]. To determine
whether they were involved in MIN6 cells, we used two struc-
turally unrelated inhibitors of the Src family kinases : herbimycin
A (IC
&!
0.5 lM in io [26]) and PP1 (IC
&!
1 lM in io [27]). The
stimulation of ERKs after treatment of MIN6 cells by glucose
was unaltered by preincubation with 2.5 lM herbimycin A for
24 h (Figure 3A) and even resulted in a slight stimulation.
Inhibition of the activation of ERKs by glucose was observed
with PP1 but only at a high concentration. Furthermore, the
Figure 3 Effect of herbimycin A and PP1 on the activation of ERKs
(A) The cells were incubated for 24 h in DMEM containing 15% (v/v) heat-inactivated fetal calf
serum with or without 2.5 lM herbimycin A. Stimulation was performed for 5 or 30 min with
16.7 mM glucose after preincubation in 2.8 mM glucose for 1 h. Abbreviations : G, 16.7 mM
glucose ; Ctl, 2.8 mM glucose. (B) Cells preincubated for 15 min with increasing concentrations
of PP1 (0, 10, 20, 30 and 40 lM) were stimulated with 10 mM glucose or 50 mM K+ (K50).
Immunoblots were performed with anti-(active ERK) antibody (upper panels) and anti-ERK2
antibody (lower panels).
activation of ERKs after stimulation with K50 was not inhibited
by PP1 (Figure 3B). Note that p60c-src is very weakly expressed
in the MIN6 cells (compared with fibroblasts) and that no
activation of either p60c-src or p59fyn was observed in kinase
assays realized on immunoprecipitated protein after stimulation
by K50 or glucose (results not shown).
Taken together, these results with tyrosine kinase inhibitors
suggest that a protein tyrosine kinase distinct from the EGF
receptor and from Src family kinases is involved in the activation
of ERKs in response to Ca#+.
The K
ATP
channel and the L-type voltage-gated Ca#+ channel
are regulated by phosphorylation [28–30], suggesting that
genistein could inhibit their activity under our conditions. Indeed,
although its effects in pancreatic b-cells are not known, genistein
has been shown to inhibit Ca#+ currents through L-type channels
in other cells [31,32]. We therefore analysed the effect of genistein
on the changes in cytoplasmic Ca#+ concentration by using the
fluorescent probe fura-2. Stimulation of MIN6 cells with glucose
(16.7 mM) led to an increase in cytoplasmic Ca#+ concentration
and to Ca#+ spikes (Figure 4A). In the presence of genistein this
increase was smaller and the spikes were absent (Figure 4B).
With K50 the increase in cytoplasmic Ca#+ was greater than with
glucose and there were no spikes (Figure 4C). In the presence of
genistein the initial peak of Ca#+ was unchanged but the
subsequent plateau was smaller (Figure 4D). Inhibition of
the plateau by genistein was confirmed by including genistein
in the perifusion medium when the plateau phase had already
been reached (Figure 4E).
These results indicate that a protein tyrosine kinase activity
might regulate the Ca#+ entry elicited by glucose and K50 in b-
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Figure 4 Impairment of the glucose- and K50-induced Ca2+ rise by genistein
The cells were incubated for 1 h in a Hepes-buffered medium containing 2.5 mM Ca2+, 1.8 mM glucose and 5 lM fura-2 acetoxymethyl ester either with (B, D) or without (A, C, E) 100 lM
genistein. The fluorescence intensities emitted at 510 nm were measured after alternate excitations at 340 and 380 nm. After a short period of equilibration in 1.8 mM glucose the cells were treated
as indicated. The successive 340 nm/380 nm fluorescence ratios reflect the cytosolic concentration of Ca2+. The traces are from one of at least three experiments.
cells. However, it should be noted that genistein at 100 lM
completely inhibits the activation of ERKs but only partly
inhibits the Ca#+ increase in response to glucose. Furthermore,
although the stimulation by K50 in the presence of genistein still
leads to a Ca#+ increase greater than that with glucose alone, it
does not result in the activation of ERKs. In addition, activation
of ERKs in response to K50 is observed very rapidly (in less than
2 min) [6] and is thus likely to be due to the initial increase in
Ca#+, which is unaffected by genistein. This suggests that a
protein tyrosine kinase is involved downstream of Ca#+ entry in
the activation of ERKs after membrane depolarization.
Involvement of protein tyrosine phosphatases in the regulation of
ERKs
It has recently been suggested that the inhibition of tyrosine
phosphatase has a critical role in the early steps of the activation
of growth factor receptors that lead to the activation of ERKs
[33]. The addition of vanadate (an inhibitor of tyrosine phos-
phatases) to MIN6 cells resulted in the activation of ERKs in the
presence of non-stimulating concentrations or even in the absence
of glucose (Figure 5A). This activation was concentration-
dependent and its onset was slow (Figure 5B). When the cells
were incubated with vanadate, either in the absence of extra-
cellular Ca#+ or in the presence of nifedipine (a blocker of the L-
type voltage-gated Ca#+ channels), the activation of ERKs was
blocked. This shows that the activation of ERKs by vanadate
depends on Ca#+ entry through L-type voltage-gated channels.
We had shown previously that forskolin, which enhances the
secretion of insulin in response to glucose [34], was also able to
enhance the activation of ERKs in response to glucose [6] ; we
found here that forskolin also potentiates the activation of ERKs
in response to vanadate (Figure 5B).
The activation of ERKs by vanadate could result from changes
in the state of phosphorylation and activity of the ionic channels.
In addition, vanadium compounds could inhibit P-type ATPase
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Figure 5 Activation of ERKs by vanadate depends on Ca2+ entry
(A) MIN6 cells were incubated for 1 h with 1 mM vanadate in the presence of 3, 1.5 or 0 mM glucose. (B) The cells were incubated with 0.1 or 1 mM vanadate for 30 min or for the indicated
durations. The stimulations were performed either in the presence of 2.5 mM Ca2+ (fi), in the absence of extracellular Ca2+ and in the presence of 1 mM EGTA (E), in the presence of 50 lM
nifedipine (N) or in the presence of 100 lM forskolin (F). (C) Measurement of the cytoplasmic Ca2+ concentration was performed as described in the legend to Figure 4. The cells were incubated
in the presence of 1.86 mM glucose and 2 mM vanadate for the indicated periods. Final depolarization of the cells was promoted by 50 mM extracellular K+ (K50).
Ca#+ pumps, which are responsible for the active transport of
Ca#+ from the cytoplasm to the endoplasmic reticulum [35]. We
therefore investigated whether vanadate could by itself increase
the cytoplasmic Ca#+ concentration. When the cells were incu-
bated in the presence of 2 mM vanadate for 30 min no increase
in Ca#+ concentration was observed (Figure 5C), although the
cells were still able to respond to K50. Moreover, after a 30 min
incubation with 1 mM vanadate, carbachol (100 lM) led to an
elevation of the cytoplasmic Ca#+ concentration, indicating that
the endoplasmic reticulum still contained Ca#+ (results not
shown). We conclude that the basal activity of the L-type Ca#+
channels (in the presence of less than 3 mM glucose) is sufficient
to obtain a Ca#+-dependent activation of ERKs in response to
vanadate.
Taken together, these results suggest that a tyrosine kinase}
tyrosine phosphatase pair is involved in the Ca#+-dependent
activation of ERKs.
Regulation of the transcription of the insulin gene by ERKs
Using PD98059, a specific inhibitor of the activation of MEK1
and MEK2, we and others have shown that although the
activation of ERKs and the regulation of insulin secretion share
important characteristics, ERKs do not regulate the secretion of
insulin, at least in short-term experiments [6,36]. Because ERKs
are translocated to the nucleus in response to glucose and are
known to regulate transcription in other systems, we investigated
their possible implication in the regulation of the insulin gene.
MIN6 cells transfected with a construct containing the fi410 to
›1 base pair region of the rat insulin I gene promoter were
treated with different concentrations of glucose either in the
presence or in the absence of a concentration of PD98059 known
to inhibit ERK activation completely [6,37]. Whereas others
Table 1 Regulation of the transcription of the insulin gene by ERKs
MIN6 cells were transiently transfected with rINSI CAT plasmid and immediately treated with
different concentrations of glucose, either with or without the MEK inhibitor PD98059 (95 lM)
in the presence of 0.7% BSA. After 36 h of treatment, the expression of CAT was measured
by an ELISA method. The expression in the cells incubated with 3 mM glucose was arbitrarily
set to 1. Results are means‡S.D. for five independent experiments. Statistical analysis with
Student’s t test : P % 0.005 between cells treated with 3 and 10 mM glucose ; P % 0.0005
between cells treated with 10 mM glucose and 10 mM glucose plus PD98059, and between
cells treated with 16 mM glucose and 16 mM glucose plus PD98059 ; P % 0.00001 between
3 mM and 16 mM glucose treated cells.
Glucose
concentration
Relative CAT expression
(mM) DMSO PD98059
3 1 0.64‡0.16
10 1.67‡0.22 0.88‡0.15
16.7 2.32‡0.12 1.26‡0.27
observed that the sustained activation of ERKs might involve a
MEK1- and MEK2-independent pathway not inhibited by
PD98059 [38], in our system PD98059 still inhibited the activation
of ERKs observed after several hours (results not shown). We
found that the rat insulin I gene promoter responds to glucose in
MIN6 cells in a concentration-dependent manner, and that
PD98059 inhibits this response (Table 1). We then determined
whether regulation of the insulin gene by ERKs could be observed
at the level of the endogenous insulin mRNA. The cells were
incubated for 18 h in 2 mM glucose and then for 36 h with two
different concentrations of glucose either in the presence or in the
absence of PD98059. Total RNA was extracted and Northern
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Figure 6 Regulation of the endogenous expression of insulin mRNA
Northern blot analysis of the expression of the insulin mRNA in MIN6 cells. The cells were
cultured in the presence of 2.8 mM glucose for 18 h and then placed in serum-free medium
containing 2.8 or 10 mM glucose with or without 95 lM PD98059. After 36 h, total RNA was
extracted and subjected to Northern blot analysis with a preproinsulin cDNA probe (upper
panel). The membrane was rehybridized with a probe specific for 18 S ribosomal RNA to control
for variations in the amount of total RNA (lower panel).
blot analysis was performed with a preproinsulin cDNA probe.
Figure 6 shows that the amount of insulin mRNA was increased
after treatment with 10 mM glucose and that this increase was
smaller in the presence of PD98059.
These results suggest that ERKs regulate insulin gene ex-
pression in response to an elevation of the extracellular glucose
concentration. Transcriptional regulation of insulin biosynthesis
has been shown to depend on both ubiquitous and b-cell-specific
factors [39–41]. The b-cell-specific human factor insulin upstream
factor, IUF1 (the analogue of the mouse factor IPF1 and the
rat factor STF1}IDX1), which binds to four sites in the human
insulin gene promoter (the A boxes), is involved in the tran-
scriptional response to glucose [42]. High concentrations of
glucose lead to the phosphorylation of IUF1 by a p38 MAP
kinase (SAPK2a) dependent mechanism [43]. This phos-
phorylation enhances the binding of IUF1 to the insulin pro-
moter. However, because there is no inhibition of the IUF1-
regulated transcription by PD98059 in the MIN6 cells [43], the
regulation of transcription of the insulin gene reported here is
unlikely to be due to phosphorylation of IUF1 by ERKs. In
addition, several other sequences of the insulin promoter are
responsive to glucose [44]. It will therefore be important to
identify the transcription factors that are regulated by the
activation of ERKs in b-cells.
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